RIYADH, Saudi Arabia, Jan. 26, 2026 /PRNewswire/ -- The Ministerial Roundtable of the third edition of the Global Labor Market Conference…
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and…
MUMBAI, India, Jan. 13, 2026 /PRNewswire/ -- In line with Standard Chartered's ("the Bank") strategic pivot to the wealth and…
CARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) -- This article contains affiliate links. If you purchase through these links, a commission…
IGF Unveils $250 Million Fund and Accelerator Programme to take Indian Brands Global at IGF ME 2025 DUBAI, UAE and NEW…
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…
SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report"…
SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration…
NEW YORK, May 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…